Skip to main content
. 2020 Sep 25;29(4):212–216. doi: 10.1136/ejhpharm-2020-002340

Table 2.

Piperacillin/tazobactam content during storage in Easypump II (B. Braun) elastomeric devices as determined using a stability indicating HPLC assay

Timepoint 90 mg/mL* 25 mg/mL†
PIP+TAZ, % remaining 95% CI (%) PIP+TAZ, % remaining 95% CI (%)
Day 0 100.0
(87.3±0.7 mg/mL)
99.2 to 100.8 100
(24.6±0.5 mg/mL)
97.9 to 102.1
Day 7 101.7 101.6 to 101.8 100.8 100.42 to 101.18
Day 11 101.1 99.83 to 102.37 102.2 102.13 to 102.27
Day 13 100.7 100.6 to 100.8 98.9 97.35 to 100.45
Day 13+1 100.8 100.22 to 101.38 101.0 100.91 to 101.09

*90 mg/ml total drug concentration: 80 mg piperacillin/10 mg tazobactam.

†25 mg/ml total drug concentration: 22 mg piperacillin/3 mg tazobactam.

PIP, piperacillin; TAZ, tazobactam.